176 related articles for article (PubMed ID: 18818403)
1. The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation.
Gizard F; Nomiyama T; Zhao Y; Findeisen HM; Heywood EB; Jones KL; Staels B; Bruemmer D
Circ Res; 2008 Nov; 103(10):1155-63. PubMed ID: 18818403
[TBL] [Abstract][Full Text] [Related]
2. Pathways of proliferation: new targets to inhibit the growth of vascular smooth muscle cells.
Marsboom G; Archer SL
Circ Res; 2008 Nov; 103(10):1047-9. PubMed ID: 18988899
[No Abstract] [Full Text] [Related]
3. PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.
Gizard F; Amant C; Barbier O; Bellosta S; Robillard R; Percevault F; Sevestre H; Krimpenfort P; Corsini A; Rochette J; Glineur C; Fruchart JC; Torpier G; Staels B
J Clin Invest; 2005 Nov; 115(11):3228-38. PubMed ID: 16239970
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells.
Ogawa D; Nomiyama T; Nakamachi T; Heywood EB; Stone JF; Berger JP; Law RE; Bruemmer D
Circ Res; 2006 Apr; 98(7):e50-9. PubMed ID: 16556873
[TBL] [Abstract][Full Text] [Related]
5. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
6. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.
Ausserlechner MJ; Obexer P; Geley S; Kofler R
Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis.
Simpson DS; Mason-Richie NA; Gettler CA; Wikenheiser-Brokamp KA
Cancer Res; 2009 Nov; 69(22):8733-41. PubMed ID: 19887614
[TBL] [Abstract][Full Text] [Related]
8. Inorganic arsenic exposure induces E2F-dependent G0/G1 arrest via an increase in retinoblastoma family protein p130 in B-cell lymphoma A20 cells.
Okamura K; Miki D; Nohara K
Genes Cells; 2013 Oct; 18(10):839-49. PubMed ID: 23890198
[TBL] [Abstract][Full Text] [Related]
9. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
10. The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.
Lin PS; McPherson LA; Chen AY; Sage J; Ford JM
DNA Repair (Amst); 2009 Jul; 8(7):795-802. PubMed ID: 19376752
[TBL] [Abstract][Full Text] [Related]
11. Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16INK4A/Rb/E2F1 and JNK signaling pathways.
Ding L; Li L; Yang J; Zhou S; Li W; Tang M; Shi Y; Yi W; Cao Y
J Med Virol; 2007 Aug; 79(8):1153-63. PubMed ID: 17597480
[TBL] [Abstract][Full Text] [Related]
12. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
Johnson DG
Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
[TBL] [Abstract][Full Text] [Related]
13. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
[TBL] [Abstract][Full Text] [Related]
14. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
[TBL] [Abstract][Full Text] [Related]
15. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway.
Sun A; Bagella L; Tutton S; Romano G; Giordano A
J Cell Biochem; 2007 Dec; 102(6):1400-4. PubMed ID: 17979151
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1.
Ng VY; Morisseau C; Falck JR; Hammock BD; Kroetz DL
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2462-8. PubMed ID: 16917105
[TBL] [Abstract][Full Text] [Related]
17. Low p16
Graham MK; Principessa L; Antony L; Meeker AK; Isaacs JT
Prostate; 2017 Mar; 77(4):374-384. PubMed ID: 27859428
[TBL] [Abstract][Full Text] [Related]
18. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
19. Telomerase Reverse Transcriptase Deficiency Prevents Neointima Formation Through Chromatin Silencing of E2F1 Target Genes.
Endorf EB; Qing H; Aono J; Terami N; Doyon G; Hyzny E; Jones KL; Findeisen HM; Bruemmer D
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):301-311. PubMed ID: 27932351
[TBL] [Abstract][Full Text] [Related]
20. Iroquois homeobox transcription factor (Irx5) promotes G1/S-phase transition in vascular smooth muscle cells by CDK2-dependent activation.
Liu D; Pattabiraman V; Bacanamwo M; Anderson LM
Am J Physiol Cell Physiol; 2016 Aug; 311(2):C179-89. PubMed ID: 27170637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
